Report cover image

Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments

Publisher Kalorama Information
Published Feb 01, 2022
Length 161 Pages
SKU # KLI17152119

Description

Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments

Cell and Gene Therapy Funding Reached $70 Billion in 2021. How Can You Keep Up with the Activity in this Industry?

A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. There are now many approved therapies with proven track records. As the tools have lowered the barriers to entry for the industry, over a thousand companies have been created or become involved. Fortunately, Kalorama Information has been tracking every significant development in CGT as part of its Cell and Gene Therapy Business Outlook Newsletter.

In concert with the technologies progressing and the proven benefits, CGT-related companies have received growing amounts of funding—and it appears likely that the trend will continue. How do you keep up with this high-interest field?

This Kalorama Information report, Cell and Gene Therapy Deals Analysis, analyzes the deals, including:
  • IPO and FPO Deals
  • SPAC Deals
  • Venture Capital and Private Funding
  • Strategic Investments
  • Mergers & Acquisitions (M&A)
  • Technology and Research Collaborations
  • Licensing Deals
  • Manufacturing and Supply Chain Deals
  • Public Outreach, Consumer Education, & Philanthropy
  • Distribution & Co-marketing Deals
  • Restructurings, Joint Ventures, Terminations and Spinoffs
  • Other Types of Deals Impacting Cell and Gene Therapy
In any novel technology field, the initial significant marketplace will be in financing and company starts. They are notoriously hard to track. Kalorama Information's analysts have already done the work for readers in this volume.

This report categorizes hundreds of cell and gene therapy deals into a usable format. Charts help to illustrate the different types of deals and frequency of different types of deals and the how the deals activity in 2021 changed per quarter.

This is an essential resource that every market watcher in Cell and Gene Therapy will need. For updated information on cell and gene therapy deals on a regular basis, add Cell and Gene Therapy Business Outlook Newsletter to your purchase. Your sales representative can assist with your purchase of both this detailed report and regularly updated information through a newsletter subscription.

Table of Contents

161 Pages
    • Introduction
    • $70.8 Billion in Funding During 2021
    • Quarterly Funding in 2021
    • VC/Private Funding in Flux
    • Strategic Investments in Cell and Gene Therapy
    • North America Sees Majority of Proceeds from IPOs, FPOs, and SPACs
    • Spike in M&A Activity During Q3 2021
    • CGT Market Sees a Broad Variety of Collaborations
    • A Look at Licensing in the Cell and Gene Therapy Market
    • Examining Manufacturing and Supply Chain Management Activity in CGT
    • CGT Market Has Dozens of Announcements Related to Public Outreach, Patient/Consumer Education, and Philanthropy
    • A Look at CGT Distribution and Co-Marketing Deals
    • A Look at Other Types of Deals Impacting Cell and Gene Therapy

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us